Should you buy 1AI.AX stock?
Last updated:
Based on market data through , StockInvest.us rates Algorae Pharmaceuticals Limited (1AI.AX) as a Sell Candidate with a technical score of -3.78 on its -10 to +10 scale. This is a downgrade from Hold in the previous daily evaluation.
- Sell signal since
- Price since signal Flat 0.00%
- 3-month trend forecast Down 0.56%
- Easy Tracking In The Watchlist
Evaluation of Algorae Pharmaceuticals Limited stock downgraded after the last trading session
(Market data through Aug 11, 2026)
No changes to the price of Algorae Pharmaceuticals Limited stock on the last trading day (Tuesday, 11th Aug 2026). During the last trading day the stock fluctuated 0% from a day low at A$0.0120 to a day high of A$0.0120. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Algorae Pharmaceuticals Limited stock with a 90% probability to be traded between A$0.0099 and A$0.0129 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
1AI.AX Signals & Forecast
There are mixed signals in the stock today. The Algorae Pharmaceuticals Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at A$0.0121. On a fall, the stock will find some support from the short-term average at A$0.0117. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, July 29, 2026, and so far it has fallen -7.69%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Algorae Pharmaceuticals Limited stock
On the downside, the stock finds support just below today's level from accumulated volume at A$0.0110 and A$0.0100. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at A$0.0100 may give a huge drop in the stock price.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved A$0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 3.64%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (1AI.AX) For The Upcoming Trading Day Of Wednesday 12th
For the upcoming trading day on Wednesday, 12th we expect Algorae Pharmaceuticals Limited to open at A$0.0120, and during the day (based on 14 day Average True Range), to move between A$0.0117 and A$0.0123, which gives a possible trading interval of +/-A$0.0006 (+/-5.47%) up or down from last closing price. If Algorae Pharmaceuticals Limited takes out the full calculated possible swing range there will be an estimated 5.47% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at A$0.0130 (8.33%) than the support at A$0.0110 (8.33%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Algorae Pharmaceuticals Limited stock A Buy?
Algorae Pharmaceuticals Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-3.777
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on August 12, 2026 - A$0.0120 ( 0.00000000000001%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
1AI.AX Performance
Trading levels for 1AI.AX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0120 | 0.00000000000001% |
| R2 | 0.0120 | 0.00000000000001% |
| R1 | 0.0120 | 0.00000000000001% |
| Price | 0.0120 | |
| S1 | 0.0120 | 0.00000000000001% |
| S2 | 0.0120 | 0.00000000000001% |
| S3 | 0.0120 | 0.00000000000001% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0.0140 | 16.67% |
| R1 | 0.0130 | 8.33% |
| Price | 0.0120 | |
| S1 | 0.0110 | -8.33% |
| S2 | 0.0100 | -16.67% |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Algorae Pharmaceuticals Limited Stock.
Buy 1AI